The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Association Between Cholesterol Level and Mortality in Dialysis Patients: Role of Inflammation and Malnutrition
Abstract
CONTEXT: Total cholesterol level is inversely associated with mortality in dialysis patients, a group at high risk of cardiovascular disease (CVD). This paradox may be explained by systemic inflammation and/or malnutrition, which are associated with lower cholesterol levels and higher mortality. OBJECTIVE: To determine the relationship between cholesterol level and outcome in patients undergoing dialysis, accounting for inflammation and malnutrition. DESIGN, SETTING, AND PARTICIPANTS: Prospective study of 823 patients enrolled from October 1995 to June 1998 who recently initiated dialysis, from 79 clinics, classified by absence or presence of inflammation and/or malnutrition (defined as serum albumin levels <3.6 mg/dL, C-reactive protein > or =10 mg/L, or interleukin 6 > or =3.09 pg/mL). MAIN OUTCOME MEASURES: All-cause and cardiovascular disease mortality. RESULTS: During a median follow-up of 2.4 years, 324 deaths (159 CVD deaths), 153 renal transplantations, and 10 losses to follow-up occurred. Average serum cholesterol level was lower in the presence of inflammation/malnutrition than in its absence. In a Cox model adjusted for age, race, and sex, a 40-mg/dL (1.0-mmol/L) increment in baseline total serum cholesterol level was associated with a decreased risk of all-cause mortality overall (relative hazard [RH], 0.92; 95% confidence interval [CI], 0.87-0.98) and in the presence of inflammation/malnutrition (RH, 0.89; CI, 0.84-0.95). In contrast, serum cholesterol level was associated with an increased risk in the absence of inflammation/malnutrition (RH, 1.32; 95% CI, 1.07-1.63). For CVD mortality, an inverse trend was not statistically significant in the presence of inflammation/malnutrition, and a positive association was evident in the absence of inflammation/malnutrition (RH, 1.41; 95% CI, 1.04-1.89). Further adjustment for traditional CVD risk factors, dialysis modality, comorbidity, and inflammatory markers attenuated the inverse association but strengthened the positive association. CONCLUSIONS: The inverse association of total cholesterol level with mortality in dialysis patients is likely due to the cholesterol-lowering effect of systemic inflammation and malnutrition, not to a protective effect of high cholesterol concentrations. These findings support treatment of hypercholesterolemia in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
The Robust Inference for the Cox Proportional Hazards Model
Lin, D. Y., & Wei, L. J. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478874 · Cited by 2,695
Lowrie, E. G., & Lew, N. L. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70364-5 · Cited by 1,976
Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m326 · Cited by 1,294
Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836
Self-citationCholesterol and Mortality: 30 Years of Follow-up From the Framingham Study
Anderson, K. M. (1987) · JAMA · doi:10.1001/jama.1987.03390160062027 · Cited by 620
Longenecker, J. C., Coresh, J., Powe, N. R., Levey, A. S., Fink, N. E., Martin, A., & Klag, M. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019641.41496.1e · Cited by 594
Self-citationInterleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
Bologa, R., Levine, D., Parker, T., Cheigh, J., Serur, D., Stenzel, K., & Rubin, A. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9669431 · Cited by 549
The Microinflammatory State in Uremia: Causes and Potential Consequences
KAYSEN, G. A. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271549 · Cited by 473
Schatz, I. J., Masaki, K., Yano, K., Chen, R., Rodriguez, B. L., & Curb, J. D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05553-2 · Cited by 426
Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients
Iseki, K., Yamazato, M., Tozawa, M., & Takishita, S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00324.x · Cited by 383
HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients
Seliger, S. L., Weiss, N. S., Gillen, D. L., Kestenbaum, B., Ball, A., Sherrard, D. J., & Stehman-Breen, C. O. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00109.x · Cited by 294
Horwich, T. B., Hamilton, M. A., MacLellan, W. R., & Fonarow, G. C. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.126519a · Cited by 279
Greenberg, A. S., Nordan, R. P., McIntosh, J. K., Calvo, J. C., Scow, R. O., & Jablons, D. M. (1992) · PubMed · Cited by 277
The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients
Kaysen, G. A., Dubin, J. A., Müller, H. G., Rosales, L. M., & Levin, N. W. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00172.x · Cited by 219
Adjusting Survival Curves for Confounders: A Review and a New Method
Nieto, F. J., & Coresh, J. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008670 · Cited by 216
Self-citationCullen, P., Schulte, H., & Assmann, G. (1997) · Circulation · doi:10.1161/01.cir.96.7.2128 · Cited by 212
Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?
Stenvinkel, P., Barany, P., Heimbürger, O., Pecoits-Filho, R., & Lindholm, B. (2002) · Kidney International · doi:10.1046/j.1523-1755.61.s80.19.x · Cited by 208
Epidemiology of cardiovascular risk factors in chronic renal disease.
Coresh, J., Longenecker, J. C., Miller, E. R., Young, H., & Klag, M. J. (1998) · PubMed · Cited by 160
Self-citationInfluence of cholesterol on survival after stroke: retrospective study
Dyker, A. G., Weir, C. J., & Lees, K. R. (1997) · BMJ · doi:10.1136/bmj.314.7094.1584 · Cited by 117
Rocco, M. V., Yan, G., Gassman, J., Lewis, J. B., Ornt, D. B., Weiss, B., & Levey, A. S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29905 · Cited by 112
Lowrie, E. G. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70172-6 · Cited by 95
The low cholesterol-mortality association in a national cohort
Harris, T. B., Feldman, J. J., Kleinman, J. C., Ettinger, W. H., Makuc, D. M., & Schatzkin, A. G. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90131-6 · Cited by 91
Attman, P.-O., Alaupovic, P., Tavella, M. J., & Knight‐Gibson, C. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.1.63 · Cited by 86
Iribarren, C. (1995) · JAMA · doi:10.1001/jama.273.24.1926 · Cited by 86
Nishizawà, Y., Shoji, T., Kakiya, R., Tsujimoto, Y., Tabata, T., Ishimura, E., Nakatani, T., Miki, T., & Inaba, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.30.x · Cited by 76
Role of Inflammation and Its Treatment in ESRD Patients
Kaysen, G. A. (2002) · Blood Purification · doi:10.1159/000046988 · Cited by 54
Baigent, C., & Wheeler, D. C. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.8.1118 · Cited by 27
Neaton, J. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400190110021 · Cited by 7
Cited by
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Mendelian Randomization as an Approach to Assess Causality Using Observational Data
Sekula, P., Del Greco M, F., Pattaro, C., & Köttgen, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016010098 · Cited by 2,351
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,427
Metadata
- Authors
- Liu, Y., Coresh, J., Eustace, J. A., Longenecker, J. C., Jaar, B., Fink, N. E., Tracy, R. P., Powe, N. R., & Klag, M. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-01-28
- Volume
- 291
- Issue
- 4
- Pages
- 451
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1990737871
- Cited by
- 777
- References
- 31
- FWCI
- 31.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.